Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

The biotech has named Jamie Coleman its chief commercial officer, per a Monday announcement, putting her in charge of the ...

Global commercial executive with expertise across product lifecycle and therapeutic areas leading transformative brands, ...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that Andrew Ratz, Ph.D., has joined the company as Senior Vice ...

Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...

The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug ...

The San Diego–based company’s molecules avoid the well-trod GLP-1 pathway in favor of an alternate route in the gut.

A new study led by Western researchers found frequent treatment with intranasal oxytocin – a hormone in the brain associated ...

The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth ... the Oceanside Unified School District in San Diego in a similar case. In the fall, dozens of school ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

In a report released on January 16, David Risinger from Leerink Partners maintained a Buy rating on AnaptysBio (ANAB – Research Report). The ...

Asian shares traded mixed Tuesday, echoing Wall Street trading, where gains for oil-and-gas producers helped offset drops for Nvidia and other Big Tech companies. Japan’s ...